Early data shows Curevac Covid-19 jab backed by Britain and Brussels is effective against UK and South Africa variants, CEO says ...News

Russia Today - News
Early data shows Curevac Covid-19 jab backed by Britain and Brussels is effective against UK and South Africa variants, CEO says
Preliminary trials show that a Covid-19 vaccine being developed by German biotech firm Curevac is effective against the UK and South Africa variants of the virus, its CEO Franz-Werner Haas told EU lawmakers on Thursday. Haas said the Curevac vaccine showed a "very nice protection" against the two strains, as he appeared in a hearing at the European Parliament. The efficacy data from early animal trials looking at how well the two-dose jab works against new forms of the virus would be published soon, he added. Also on rt.com Germany’s CureVac starts pivotal global trial for C

Hence then, the article about early data shows curevac covid 19 jab backed by britain and brussels is effective against uk and south africa variants ceo says was published today ( ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Early data shows Curevac Covid-19 jab backed by Britain and Brussels is effective against UK and South Africa variants, CEO says )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
myMOTHERLODE - before 5 hours & 43 minute